← Back to Investors

Illumina Ventures

Illumina Ventures is an independent venture fund focused on investing in early-stage genomics and precision health companies. While operationally independent from Illumina, Inc., the fund leverages deep genomics expertise and the broader Illumina ecosystem to support portfolio companies.

Location
San Francisco, California, USA
Founded
2016
AUM
$330M+
Investment Range
$500K - $20M
Portfolio Companies
32
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Investment Thesis

Illumina Ventures invests in companies at the cutting edge of genomics and precision health. They focus on applications enabled by genomic sequencing, including diagnostics, therapeutics, synthetic biology, and computational biology. Their deep domain expertise allows them to identify and support the most innovative companies in the space.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Nick Naclerio - Founding Partner
  • Julie Grant - Partner
  • Mostafa Ronaghi, PhD - Founding Partner

Other Key Team Members

  • Michelle Cai - Principal

Focus Areas

  • Genomics and sequencing applications
  • Precision medicine
  • Cancer diagnostics
  • Liquid biopsy
  • Reproductive health
  • Infectious disease
  • Synthetic biology
  • Computational biology

Notable Investments

  • Grail - Early investor (cancer detection, acquired by Illumina)
  • Freenome - Cancer screening
  • Helix - Population genomics
  • Tempus - Precision medicine AI

Sources

Portfolio Companies

NameLocationFoundedCategories
Actym TherapeuticsBerkeley, California, USA2017
oncologydrug-delivery+3
Alamar BiosciencesFremont, California, USA2019
proteomicsdiagnostics+2
Arbor BiotechnologiesCambridge, Massachusetts, USA2016
biotechgene-editing+3
Arima GenomicsSan Diego, California, USA2016
genomicschromatin+3
Attovia Therapeutics--
biotechtherapeutics
Broken String BiosciencesCambridge, United Kingdom2020
gene-therapycell-therapy+4
Bullseye BiosciencesSan Francisco Bay Area, California, USA2020
biotechdiagnostics+2
CernosticsPittsburgh, Pennsylvania, USA2011
spatial-biologypathology+4
DeepSeq.AI--
aigenomics+3
Delfi DiagnosticsBaltimore, Maryland, USA2019
diagnosticscancer-detection+3
Encoded TherapeuticsSouth San Francisco, California, USA2016
gene-therapytherapeutics+3
Fluent BioSciencesWatertown, Massachusetts, USA2019
single-cell-sequencinggenomics+3
Fuze HealthCalifornia, USA2020
digital-healthhealthcare-technology+2
Hepta BioBoston, Massachusetts, USA2020
diagnosticsliver-disease+3
Iambic TherapeuticsSan Diego, California, USA2019
therapeuticsdrug-discovery+2
Integrated BiosciencesSan Carlos, California, USA2020
synthetic-biologyai+4
Kodikaz Therapeutic SolutionsOrlando, Florida, USA2020
gene-therapyviral-vectors+3
Lightcast BioCambridge, Massachusetts, USA2020
single-cellcell-profiling+3
NanoCellect BiomedicalSan Diego, California, USA2009
microfluidicscell-sorting+5
Precede BiosciencesSan Diego, California, USA2021
liquid-biopsydiagnostics+3
Predicta BiosciencesBoston, Massachusetts, USA2020
aimultiomics+3
Protillion BiosciencesCambridge, Massachusetts, USA2021
biotechprotein-engineering+2
Rebus BiosystemsSanta Clara, California, USA2017
biotechspatial-genomics+3
RedShiftBioBurlington, Massachusetts, USA2015
biotechbiomolecules+2
RibometrixDurham, North Carolina, USA2016
rna-therapeuticsdrug-discovery+3
SerimmuneSanta Barbara, California, USA2016
immunologybiomarkers+3
Serinus BiosciencesSan Diego, California, USA2019
oncologyprecision-medicine+3
Sherlock BiosciencesCambridge, Massachusetts, USA2019
diagnosticsmolecular-diagnostics+3
SonotheraBoulder, Colorado, USA2020
gene-therapyultrasound+3
Stilla TechnologiesVillejuif, France2016
diagnosticsdigital-pcr+3
Syntax BioBoston, Massachusetts, USA2021
stem-cellscell-differentiation+3
TagomicBoston, Massachusetts, USA2021
multiomicsgenomic-medicine+3